REGN9533

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN9533, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Safety and Tolerability Study of REGN9533 in Healthy Adults [Phase 1]